ICD-10-CM Billable Code

Q79.60

Ehlers-Danlos syndrome, unspecified

Clinical Classification Guidelines

Medical Intelligence & Overview

Ehlers-Danlos syndrome (EDS) is a group of inherited disorders that affect the body's connective tissues, which provide support and structure to the skin, joints, blood vessels, and organs. The term 'unspecified' in ICD-10 code Q79.60 is used when the specific type of EDS has not been classified. Individuals with this condition may experience symptoms such as overly flexible joints, stretchy skin, and fragile tissues. Although there is no cure for EDS, various management strategies can help reduce complications and improve quality of life.

Causes & Symptoms

Clinical Causes: Genetic mutations affecting collagen or other connective tissue components Inheritance patterns vary; most cases are inherited in an autosomal dominant or recessive manner In some instances, the exact genetic cause may not be identified, leading to an unspecified classification

Key Symptoms: Hyperextensible or overly flexible joints that may dislocate easily Skin that is unusually stretchy, soft, or fragile Fragility of blood vessels, leading to easy bruising or bleeding Chronic joint pain or instability Delayed wound healing and thin, stretchable scars Muscle weakness or fatigue In some cases, dental abnormalities or early-onset varicose veins

Diagnostic & Treatment

Diagnosis Path: Diagnosing Ehlers-Danlos syndrome involves a comprehensive clinical evaluation that assesses joint flexibility, skin characteristics, and family history. Doctors may perform physical exams, review medical histories, and conduct genetic testing to identify mutations associated with different types of EDS. However, when the specific type is not determined, the diagnosis is categorized as unspecified. Additional tests, such as imaging studies or skin biopsies, might be used to evaluate tissue integrity and rule out other conditions.

Treatment Protocols: While there is no cure for Ehlers-Danlos syndrome, various treatments aim to manage symptoms and prevent complications. Strategies include:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is Q79.60 a billable ICD-10 code?
Yes, Q79.60 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report Q79.60?
Clinical documentation must specify the nature of Ehlers-Danlos syndrome, unspecified and any associated comorbidities for accurate reporting.

Cite this Clinical Reference